Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Benelli

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
NPJ Breast Cancer|February 19, 2022
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancerIlenia Migliaccio, Marta Paoli, Emanuela Risi, et al.
Molecular and Cellular Biochemistry|May 23, 2025
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Cancer Treatment Reviews|December 28, 2020
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancerIlenia Migliaccio, Martina Bonechi, Amelia McCartney, et al.
Communications Biology|November 3, 2021
Charting differentially methylated regions in cancer with Rocker-methMatteo Benelli, Gian Marco Franceschini, Alberto Magi, et al.
Biostatistics (Oxford, England)|March 9, 2010
A very fast and accurate method for calling aberrations in array-CGH dataMatteo Benelli, Giuseppina Marseglia, Genni Nannetti, et al.
Breast Care (Basel, Switzerland)|December 14, 2017
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of ResponseCristina Guarducci, Martina Bonechi, Giulia Boccalini, et al.
European Journal of Medical Genetics|December 3, 2014
16p11.2 de novo microdeletion encompassing SRCAP gene in a patient with speech impairment, global developmental delay and behavioural problemsFrancesca Gerundino, Guiseppina Marseglia, Chiara Pescucci, et al.
Cancers|December 3, 2020
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung CancerVeronica Ghini, Letizia Laera, Beatrice Fantechi, et al.
Human Heredity|August 19, 2011
EX-HOM (EXome HOMozygosity): a proof of principleTommaso Pippucci, Matteo Benelli, Alberto Magi, et al.
Oncotarget|April 21, 2016
Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterationsValentina Montagnani, Matteo Benelli, Alessandro Apollo, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
NPJ Breast Cancer|February 19, 2022
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancerIlenia Migliaccio, Marta Paoli, Emanuela Risi, et al.
Molecular and Cellular Biochemistry|May 23, 2025
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Cancer Treatment Reviews|December 28, 2020
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancerIlenia Migliaccio, Martina Bonechi, Amelia McCartney, et al.
Communications Biology|November 3, 2021
Charting differentially methylated regions in cancer with Rocker-methMatteo Benelli, Gian Marco Franceschini, Alberto Magi, et al.
Biostatistics (Oxford, England)|March 9, 2010
A very fast and accurate method for calling aberrations in array-CGH dataMatteo Benelli, Giuseppina Marseglia, Genni Nannetti, et al.
Breast Care (Basel, Switzerland)|December 14, 2017
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of ResponseCristina Guarducci, Martina Bonechi, Giulia Boccalini, et al.
European Journal of Medical Genetics|December 3, 2014
16p11.2 de novo microdeletion encompassing SRCAP gene in a patient with speech impairment, global developmental delay and behavioural problemsFrancesca Gerundino, Guiseppina Marseglia, Chiara Pescucci, et al.
Cancers|December 3, 2020
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung CancerVeronica Ghini, Letizia Laera, Beatrice Fantechi, et al.
Human Heredity|August 19, 2011
EX-HOM (EXome HOMozygosity): a proof of principleTommaso Pippucci, Matteo Benelli, Alberto Magi, et al.
Oncotarget|April 21, 2016
Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterationsValentina Montagnani, Matteo Benelli, Alessandro Apollo, et al.
Pageof 9